- In January 2024, AnX Robotica advances gastrointestinal diagnostics with FDA-cleared NaviCam SB Capsule Endoscopy for patients aged 2+, enhanced by ProScan AI-assisted reading. The NaviCam Tether enables esophageal visualization, expanding diagnostic capabilities. With a growing NaviCam platform, including MCCE and colon systems, AnX delivers innovative, non-invasive solutions for comprehensive GI tract evaluation
- In February 2023, AnX Robotica launches the FDA-cleared NaviCam Small Bowel System in the U.S., featuring aspherical lens technology for enhanced imaging and reduced distortion. With faster download and processing times, the system improves diagnostic efficiency for small bowel diseases, supporting timely evaluation of obscure GI bleeding and inflammatory bowel disease (IBD)
- In August 2024, Boston Scientific launched the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic gallbladder drainage in acute cholecystitis patients unsuitable for surgery. Using EUS guidance, it enables internal bile drainage, avoiding external drains. Clinical studies show fewer complications and faster recovery compared to traditional methods, offering a minimally invasive option for high-risk patients
- In January 2025, CapsoVision’s CapsoCam Plus has received FDA clearance for pediatric use in patients aged two and above. Offering 360° panoramic imaging without wearable equipment, it provides a stress-free, non-invasive alternative to traditional capsule endoscopy, enhancing diagnostic accuracy and comfort for children while streamlining procedures for healthcare providers through CapsoCloud integration
- In May 2022 , Cook Medical introduced the Evolution Biliary Controlled-Release Stents, designed to provide uniform radial force, optimal flexibility, and conformability. These stents are available in various lengths and are intended to improve outcomes in patients with biliary obstructions
